Analytical Data
-
Gene name
PPP1R2P9
- Application
-
Alternative Names
PPP1R2C; PPP1R2P9; Protein phosphatase inhibitor 2 family member C; PPP1R2 family member B; Protein phosphatase 1; regulatory subunit 2 pseudogene 9; Type-1 protein phosphatase inhibitor 4; I-4
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O14990
-
Expression Region
1-202 aa
-
AA Sequence
MSASTSSHRP IKGILKNKSS SGSSVATSGQ QSGGTIQDVK RKKSQKWDES SILAAHRATY RDYDLMKANE PGTSYMSVQD NGEDSVRDVE GEDSVRGVEG KEATDASDHS CEVDEQESSE AYMRKILLHK QEKKRQFEMR RRLHYNEELN IKLARQLMWK ELQSEDNENE ETPQGTNEEK TAAEESEEAP LTGGLQTQSC DP
-
Molecular Weight
22.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPP1R2P9 is a pseudogene of the PPP1R2 gene, which is involved in the regulation of protein phosphatase 1 (PP1), a critical enzyme known for its role in various cellular processes, including cell cycle regulation, glycogen metabolism, and muscle contraction. The study of PPP1R2P9 has gained attention due to its potential implications in gene regulation and cellular signaling mechanisms. Pseudogenes like PPP1R2P9 are often thought to be non-functional; however, emerging evidence suggests they may play roles in regulating gene expression through mechanisms such as competitive endogenous RNA (ceRNA) activities or influencing the expression of their functional counterparts. Investigating the expression patterns and possible functions of PPP1R2P9 can provide insights into its role in human health and disease, particularly in conditions where PP1 activity is dysregulated. Understanding the interplay between pseudogenes and their associated genes can enhance our knowledge of the complex regulatory networks governing cellular functions and may reveal novel therapeutic targets in diseases such as cancer and metabolic disorders. As research progresses, the functional relevance of PPP1R2P9 in both physiological and pathological contexts will be further delineated, offering potential avenues for innovative approaches in molecular biology and medicine.
